The UK MHRA has warned consumers not to use the following seven unauthorised herbal products that are being marketed as dietary supplements News item 19 January 2013 Pages: 2 - 2
“Patient reports contribute substantially to the reporting of ADRs, both in quantity and quality” Non-clinical study 19 January 2013 Pages: 2 - 2
According to the MHRA, a total of 5 fatal ADR reports in patients receiving rimonabant [Acomplia] have been received in the UK News item 19 January 2013 Pages: 3 - 3
Short-term antipsychotic use is associated with serious events News item 19 January 2013 Pages: 4 - 4
‘Undesirable’ lipid levels linked to HRT-related coronary events News item 19 January 2013 Pages: 5 - 5
Antipsoriatic effect of methotrexate reduced by concomitant folic acid News item 19 January 2013 Pages: 5 - 5
Rosiglitazone [Avandia] does not increase the risk of cardiovascular mortality and morbidity in patients with type 2 diabetes mellitus Media release 19 January 2013 Pages: 5 - 5